SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-012904
Filing Date
2019-11-14
Accepted
2019-11-14 09:00:10
Documents
4
Period of Report
2019-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx8k.htm 8-K 56887
2 EXHIBIT 10.1 ex10-1.htm EX-10 314116
3 EXHIBIT 10.2 ex10-2.htm EX-10 101288
4 PRESS RELEASE ex99-1.htm EX-99 16335
  Complete submission text file 0001654954-19-012904.txt   489830
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 191216705
SIC: 2834 Pharmaceutical Preparations